Edition:
United States

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

9.13USD
3:59pm EST
Change (% chg)

$-0.43 (-4.50%)
Prev Close
$9.56
Open
$9.90
Day's High
$9.90
Day's Low
$9.13
Volume
9,391
Avg. Vol
--
52-wk High
$11.98
52-wk Low
$9.13

Chart for

About

Krystal Biotech, Inc. is a gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes... (more)

Overall

Beta: --
Market Cap(Mil.): $97.87
Shares Outstanding(Mil.): 10.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results

Nov 13 2017

BRIEF-Krystal Biotech says KB103 granted orphan drug designation by FDA

* Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa

Nov 07 2017

Earnings vs. Estimates